Nature Structural & Molecular BiologyGenetic & Genomic MedicinePeer-reviewed journal article
African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1
Pilar Álvarez JereziD, Peter Wild CreaiD, Daniel M. RamosiD, Emil Karl GustavssoniD, Mandy Radefeldt, Andrey DamianoviD, Mary B. MakariousiD, Oluwadamilola Omolara OjoiD, Kimberley J. BillingsleyiD, Laksh MalikiD, Kensuke DaidaiD, Sarah Bromberek, Fangle Hu, Zachary SchneideriD, Aditya SurapaneniiD, Julia Stadler, Mie RizigiD, Huw R. MorrisiD, Caroline B. PantazisiD, Hampton L. LeonardiD, Laurel A. ScreveniD, Yue Andy QiiD, Mike A. NallsiD, Sara Bandrés‐CigaiD, John HardyiD, , Cornelis BlauwendraatiD
Abstract
Recently, a novel African ancestry specific Parkinsons disease (PD) risk signal was identified at the gene encoding glucocerebrosidase (GBA1). This variant (rs3115534-G) is carried by [~]50% of West African PD cases and imparts a dose-dependent increase in risk for disease. The risk variant has varied frequencies across African ancestry groups, but is almost absent in European and Asian ancestry populations. GBA1 is a gene of high clinical and therapeutic interest. Damaging bi-allelic protein-coding variants cause Gaucher disease and mono-allelic variants confer risk for PD and Dementia with Lewy Bodies, likely by reducing the function of glucocerebrosidase. Interestingly, the novel African ancestry specific GBA1 risk variant is a non-coding variant, suggesting a different mechanism of action. Using full length RNA transcript sequencing, we identified intron 8 expression in risk variant carriers (G) but not in non-variant carriers (T). Antibodies targeting the N-terminus of glucocerebrosidase showed that this intron-retained isoform is likely not protein coding and subsequent proteomics did not identify a shorter protein isoform, suggesting the disease mechanism is RNA-based. CRISPR editing of the reported index variant (rs3115534) revealed that this is the responsible sequence alteration driving production of these intron 8 containing transcripts. Follow-up analysis of this variant showed that it is in a key intronic branchpoint sequence and therefore has important implications in splicing and disease. In addition, when measuring glucocerebrosidase activity we identified a dose-dependent reduction in risk variant carriers (G). Overall, we report the functional effect of a GBA1 non-coding risk variant, which acts by interfering with the splicing of functional GBA1 transcripts, resulting in reduced protein levels and reduced glucocerebrosidase activity. This understanding reveals a novel therapeutic target in an underserved and underrepresented population.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: experimental assay
- Citations
- 23
- FWCI
- 6.50
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genome-wide association study of glucocerebrosidase activity modifiers.
Emma N. Somerville, Lynne Krohn, … Ziv Gan‐Or·Molecular NeurobiologyPeer-reviewed·Apr 29, 2025
- Polygenic Parkinson's disease genetic risk score as risk modifier of parkinsonism in Gaucher disease
Cornelis Blauwendraat, Nahid Tayebi, … Ellen Sidransky·Movement DisordersPeer-reviewed·Mar 3, 2023
- Penetrance of Parkinson's disease in GBA1 carriers is depending on the variant severity and polygenic background
Emadeldin Hassanin, Zied Landoulsi, … Dheeraj Reddy Bobbili·medRxiv·Jan 23, 2025
- Genetic modifiers of risk and age at onset in GBA associated Parkinson disease and Lewy body dementia
Cornelis Blauwendraat, Xylena Reed, … Andrew Singleton·BrainPeer-reviewed·Oct 23, 2019
- Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinsons Disease in African and African Admixed Populations
Mie Rizig, Sara Bandrés‐Ciga, … Francis Ojini·The Lancet NeurologyPeer-reviewed·Nov 1, 2023
- The non-coding GBA1 rs3115534 variant is associated with REM sleep behavior disorder in Nigerians
Oluwadamilola Omolara Ojo, Sara Bandrés‐Ciga, … Njideka Ulunma Okubadejo·Movement DisordersPeer-reviewed·Feb 23, 2024